Literature DB >> 19450645

WHO position on HPV vaccines.

.   

Abstract

The WHO Position Paper on Vaccines against Human Papillomavirus (HPV): This article presents the WHO recommendations for use of the HPV vaccine excerpted from the recently published WHO Position on HPV Vaccines. These recommendations were formulated in a multiyear collaboration involving internal and external experts in the field, culminating in production of a detailed Background paper summarizing the evidence. After a series of meetings and careful consideration of the evidence for HPV vaccine introduction, WHO's Strategic Advisory Group of Experts (SAGE) on vaccines and immunization recommended use of HPV vaccine in November 2008. WHO published a complete position paper in April 2009, which presents the WHO Position. Additional evidence including a detailed Background paper summarizing the evidence last presented to SAGE is available at http://www.who.int/immunization/documents/positionpapers/en/index.html.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450645     DOI: 10.1016/j.vaccine.2009.05.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Knowledge, attitudes and practices regarding human papillomavirus vaccination among young women attending a tertiary institution in Singapore.

Authors:  Qing Yuan Zhuang; Ru Xin Wong; Wei Ming Darren Chen; Xiao Xuan Guo
Journal:  Singapore Med J       Date:  2016-06       Impact factor: 1.858

2.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

Review 3.  Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.

Authors:  Paul L McCormack; Elmar A Joura
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

4.  Knowledge of and attitude toward human papillomavirus infection and vaccines among female nurses at a tertiary hospital in Nigeria.

Authors:  Christian Chigozie Makwe; Rose Ihuoma Anorlu
Journal:  Int J Womens Health       Date:  2011-09-13

5.  HPV vaccination in boys: Determining the clinical relevance of this strategy.

Authors:  Harald Zur Hausen; Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2017-08-23       Impact factor: 2.447

6.  Prevalence of human papillomavirus in adolescent girls before reported sexual debut.

Authors:  Catherine F Houlihan; Silvia de Sanjosé; Kathy Baisley; John Changalucha; David A Ross; Saidi Kapiga; Jose M Godinez; Ivana Bozicevic; Richard J Hayes; Deborah Watson-Jones
Journal:  J Infect Dis       Date:  2014-04-16       Impact factor: 5.226

7.  Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania.

Authors:  Catherine F Houlihan; Kathy Baisley; Ignacio G Bravo; Saidi Kapiga; Silvia de Sanjosé; John Changalucha; David A Ross; Richard J Hayes; Deborah Watson-Jones
Journal:  Int J Epidemiol       Date:  2016-03-04       Impact factor: 7.196

8.  Variability of high risk HPV genotypes among HIV infected women in Mwanza, Tanzania- the need for evaluation of current vaccine effectiveness in developing countries.

Authors:  Fridolin Mujuni; Mariam M Mirambo; Peter Rambau; Korn Klaus; Muller Andreas; Dismas Matovelo; Mtebe Majigo; Christa Kasang; Stephen E Mshana
Journal:  Infect Agent Cancer       Date:  2016-08-19       Impact factor: 2.965

9.  Knowledge about cervical cancer and awareness about human papillomavirus vaccination among medical students in Jordan.

Authors:  Mervat M Alsous; Ahlam Ali; Sayer Al-Azzam; Reema Karasneh; Haneen Amawi
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

10.  Breast cancer and cervical cancer prevention programmes carried out by local government units in Poland in 2009-2014.

Authors:  Anna Augustynowicz; Aleksandra Czerw; Mariola Borowska; Adam Fronczak; Andrzej Deptała
Journal:  Oncotarget       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.